From December 1st, these medicines must not be sold on the Internet!

The State Administration of Market Supervision announced the "Measures for the Supervision and Administration of Drug Network Sales" (hereinafter referred to as the "Administrative Measures"), which will be implemented on December 1, 2022.

The management measures further implement the main responsibility of drug management enterprises. Clarify the qualifications and requirements of the pharmaceutical business enterprise engaged in drug network sales, and clarify the vaccine, blood products, anesthesia drugs, psychotropic drugs, medical drugs, radioactive drugs, pharmaceutical and chemicals and other countries in accordance with the law Do not sell on the Internet.

The management measures vigorously compact the responsibility of the drug network sales platform. Clarify that third -party platforms should set up drug quality and safety management institutions, equipped with pharmacy and technical personnel, and establish and implement drug quality and safety, pharmaceutical information display, prescription review, prescription drug real -name purchase, drug distribution, transaction record preservation, adverse reaction report, complaint report processing, etc. Management system and record in accordance with regulations. At the same time, the platform is required to sign an agreement with the drug network sales enterprise to clarify the responsibility of drug quality and safety between the two parties. It stipulates that the platform shall perform the obligations and reports of the stop service and report of the suspension of the audit, inspection and monitoring, and the discovery of serious violations. Emergency treatment and coordination obligations in supervision and inspection.

Considering the safety risks of medication and online consistency management requirements, the management measures clearly implement a real -name system for the sales of prescription drug networks, and conduct prescription review and deployment in accordance with regulations; stipulate that prescription drugs and over -the -counter drugs should be distinguished and display Direct information such as packaging, labels and other information directly; before the prescription review, no information such as instructions shall be displayed, and the relevant services of prescription medicine purchase shall not be provided. It is intended to emphasize the management requirements of "first medicines and then medicines" and prescription review. At the same time, before the sales of prescription drugs, consumers should fully inform consumers to fully inform the relevant risk warning information and confirm their knowledge by consumers, and effectively prevent the safety risk of medication.

Source: Rule of Law Daily

PSAs

- END -